(Q41177950)

27 September 2017

1 reference

title

Novel drugs and current therapeutic approaches in the treatment of heart failure (English)

1 reference

27 September 2017

V V Bonarjee

1

1 reference

27 September 2017

K Dickstein

series ordinal

2

1 reference

27 September 2017

language of work or name

1 reference

1 March 1996

1 reference

27 September 2017

1 reference

27 September 2017

51

1 reference

27 September 2017

3

1 reference

27 September 2017

347-358

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651030-00001

27 September 2017

0 references

cites work

Controlled trials with beta blockers in heart failure: metoprolol as the prototype

1 reference

12 December 2020

Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.

1 reference

12 December 2020

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

1 reference

12 December 2020

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

12 December 2020

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

1 reference

12 December 2020

Cough and ACE inhibitors

1 reference

12 December 2020

Value of carvedilol in congestive heart failure secondary to coronary artery disease.

1 reference

12 December 2020

Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels

1 reference

12 December 2020

Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure

1 reference

12 December 2020

The physiologic basis of diuretic synergism: its role in treating diuretic resistance

1 reference

12 December 2020

Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure

1 reference

12 December 2020

Congestive heart failure induced by six of the newer antiarrhythmic drugs

1 reference

12 December 2020

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy

1 reference

12 December 2020

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure

1 reference

12 December 2020

Metolazone in treatment of severe refractory congestive cardiac failure

1 reference

12 December 2020

Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure.

1 reference

12 December 2020

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

1 reference

12 December 2020

Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure

1 reference

12 December 2020

Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group

1 reference

12 December 2020

The role of neutral endopeptidase in dogs with evolving congestive heart failure

1 reference

12 December 2020

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

1 reference

12 December 2020

Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

1 reference

12 December 2020

Inhibitors of ANF metabolism. Potential therapeutic agents in cardiovascular disease

1 reference

12 December 2020

Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition

1 reference

12 December 2020

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure.

1 reference

12 December 2020

Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure.

1 reference

12 December 2020

Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy

1 reference

12 December 2020

Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure

1 reference

12 December 2020

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

12 December 2020

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1 reference

12 December 2020

Pharmacology and pharmacokinetics of amiodarone

1 reference

12 December 2020

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

1 reference

12 December 2020

Adrenergic effects on the biology of the adult mammalian cardiocyte

1 reference

12 December 2020

Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema

1 reference

12 December 2020

The pharmacology of carvedilol

1 reference

12 December 2020

Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure

1 reference

12 December 2020

Cardiology--II: Treatment of heart failure and atrial fibrillation and arrhythmias

1 reference

12 December 2020

Sudden unexpected death in patients with congestive heart failure: a second frontier

1 reference

12 December 2020

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

12 December 2020

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

12 December 2020

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition

1 reference

12 December 2020

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

12 December 2020

Is there a role for epoprostenol in the management of heart failure?

1 reference

12 December 2020

The clinical significance of nitrate tolerance in patients with chronic heart failure

1 reference

12 December 2020

Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril

1 reference

12 December 2020

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure

1 reference

12 December 2020

Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group.

1 reference

12 December 2020

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).

1 reference

12 December 2020

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

1 reference

12 December 2020

Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

12 December 2020

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

1 reference

12 December 2020

Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure

1 reference

12 December 2020

The myocardial renin-angiotensin system: existence, importance, and clinical implications

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction

1 reference

12 December 2020

Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition

1 reference

12 December 2020

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review

1 reference

12 December 2020

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

12 December 2020

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

12 December 2020

Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

12 December 2020

Effect on exercise performance of enalapril therapy initiated early after myocardial infarction. Nordic Enalapril exercise Trial

1 reference

12 December 2020

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

1 reference

12 December 2020

Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

1 reference

12 December 2020

Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone

1 reference

12 December 2020

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

1 reference

12 December 2020

Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study

1 reference

12 December 2020

Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

The broad substrate specificity of human angiotensin I converting enzyme

1 reference

12 December 2020

Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure

1 reference

12 December 2020

Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure

1 reference

12 December 2020

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

12 December 2020

Long-term digitalis therapy improves left ventricular function in heart failure

1 reference

12 December 2020

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Neurohumoral activation during exercise in congestive heart failure

1 reference

12 December 2020

Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.

1 reference

12 December 2020

Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure

1 reference

12 December 2020

Pharmacology of flosequinan

1 reference

12 December 2020

Why patients with congestive heart failure die: arrhythmias and sudden cardiac death

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

1 reference

12 December 2020

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

1 reference

12 December 2020

Side effects from amiodarone

1 reference

12 December 2020

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

12 December 2020

Plasma norepinephrine in congestive heart failure

1 reference

12 December 2020

Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Dose-ranging effects of candoxatril on elimination of exogenous atrial natriuretic peptide in chronic heart failure

1 reference

12 December 2020

Classification of positive inotropic agents

1 reference

12 December 2020

Endothelin in human congestive heart failure

1 reference

12 December 2020

Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

1 reference

12 December 2020

Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy. CONSENSUS II Multi-Echo Study Group

1 reference

12 December 2020

10.2165/00003495-199651030-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference